- Comparison of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Injection: Ranibizumab versus Bevacizumab
-
Hwang DJ, Kim YW, Woo SJ, Park KH
- KMID: 2157986
- J Korean Med Sci.
- 2012 Dec;27(12):1580-1585.
- doi: 10.3346/jkms.2012.27.12.1580
The aim of this study was to compare the incidence of systemic adverse events in patients treated with intravitreal injections of bevacizumab or ranibizumab, and to evaluate whether compared to... -
- CITED
-
- Close
- SHARE
-
- Close
- Assessment of Patient Pain Experience during Intravitreal 27-Gauge Bevacizumab and 30-Gauge Ranibizumab Injection
-
Guler M, Bilgin B, Capkin M, Simsek A, Bilak S
- KMID: 2363758
- Korean J Ophthalmol.
- 2015 Jun;29(3):190-194.
- doi: 10.3341/kjo.2015.29.3.190
PURPOSE: To compare pain scores of patients during intravitreal 27-gauge bevacizumab and 30-gauge ranibizumab injection procedures. METHODS: Seventy eyes of 70 patients who had not previously undergone intravitreal anti-vascular endothelial growth... -
- CITED
-
- Close
- SHARE
-
- Close
